About Encodia
Encodia is a company based in San Diego (United States) founded in 2015. Encodia has raised $75 million across 4 funding rounds from investors including ARE, Arch Venture Partners and Deerfield. The company has 85 employees as of December 31, 2022. Encodia offers products and services including ProteoCode. Encodia operates in a competitive market with competitors including Tierra Biosciences, Amide Technologies, Kesmalea, mk2 Biotechnologies and Aquagene, among others.
- Headquarter San Diego, United States
- Employees 85 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Encodia, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$75 M (USD)
in 4 rounds
-
Latest Funding Round
$75 M (USD), Series C
Jan 27, 2021
-
Investors
ARE
& 9 more
-
Employee Count
85
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Encodia
Encodia offers a comprehensive portfolio of products and services, including ProteoCode.
Enables scalable NGS-based analysis of protein libraries for health innovations.
People of Encodia
Unlock access to complete
Unlock access to complete
Funding Insights of Encodia
Encodia has successfully raised a total of $75M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $75 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Encodia
Encodia has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Arch Venture Partners and Deerfield.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Locked | Locked | Locked | |
|
Corporate backed venture capital fund investing in multiple sectors
|
Locked | Locked | Locked | |
|
Venture capital firm focused on life science companies
|
Locked | Locked | Locked |
Investor details for Encodia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Encodia
Investment portfolio details for Encodia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Encodia
Detailed financials for Encodia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Encodia Comparisons
Peer comparison for Encodia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Encodia
Encodia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tierra Biosciences, Amide Technologies, Kesmalea, mk2 Biotechnologies and Aquagene, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based tools for protein development and custom synthesis are offered.
|
|
| Locked | Locked | Locked |
Automated peptide synthesis platform is developed with precision reagents.
|
|
| Locked | Locked | Locked |
Protein homeostasis modulators are developed for therapeutic applications.
|
|
| Locked | Locked | Locked |
Peptides and proteins are developed for life science applications.
|
|
| Locked | Locked | Locked |
Produces high-quality recombinant proteins for research and industrial applications.
|
Detailed competitors of Encodia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Encodia
Complete news archive for Encodia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Encodia
Encodia was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Encodia is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Encodia is a funded company, having raised a total of $75M across 4 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Encodia is 85.
Encodia was founded in 2015 and is based in San Diego, United States. Integrative proteomic analysis is supported through developed technology platforms. Fluidics-based instruments are offered to facilitate automatic multi-step biochemical and chemical processes. Operations focus on the biotechnology sector, with services centered on proteomic tools for research applications. The companys domain is encodia.com.
Encodia's top competitors include Tierra Biosciences, Amide Technologies and Kesmalea.
Encodia offers ProteoCode.
Encodia has 10 investors. Key investors include ARE, Arch Venture Partners, Deerfield, Google Ventures, and Decheng Capital.